Cargando…

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

INTRODUCTION: The use of immune-checkpoint inhibitors has drastically improved the management of patients with non-small cell lung cancer (NSCLC), but innate and acquired resistances are hurdles needed to be solved. Immunomodulatory drugs that can reinvigorate the immune cytotoxic activity, in combi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redin, Esther, Garmendia, Irati, Lozano, Teresa, Serrano, Diego, Senent, Yaiza, Redrado, Miriam, Villalba, Maria, De Andrea, Carlos E, Exposito, Francisco, Ajona, Daniel, Ortiz-Espinosa, Sergio, Remirez, Ana, Bertolo, Cristina, Sainz, Cristina, Garcia-Pedrero, Juana, Pio, Ruben, Lasarte, Juan, Agorreta, Jackeline, Montuenga, Luis M, Calvo, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Clinical/Translational Cancer Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931761/ https://www.ncbi.nlm.nih.gov/pubmed/33658304 http://dx.doi.org/10.1136/jitc-2020-001496

Ejemplares similares

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
por: Valencia, Karmele, et al.
Publicado: (2022)

The SRC Inhibitor Dasatinib Induces Stem Cell-Like Properties in Head and Neck Cancer Cells that are Effectively Counteracted by the Mithralog EC-8042
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019)

The Complement System in Ovarian Cancer: An Underexplored Old Path
por: Senent, Yaiza, et al.
Publicado: (2021)

A model based on the quantification of complement C4c, CYFRA 21–1 and CRP exhibits high specificity for the early diagnosis of lung cancer
por: AJONA, DANIEL, et al.
Publicado: (2021)

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
por: Villalba, Maria, et al.
Publicado: (2019)

Adaptive metabolic rewiring to chronic SFK inhibition
por: Pinedo-Carpio, Edgar, et al.
Publicado: (2016)

Complement C4d-specific antibodies for the diagnosis of lung cancer
por: Ajona, Daniel, et al.
Publicado: (2017)

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022)

VEGF(121)b and VEGF(165)b are weakly angiogenic isoforms of VEGF-A
por: Catena, Raúl, et al.
Publicado: (2010)

Role of sfk1 Gene in the Filamentous Fungus Penicillium roqueforti
por: Torrent, Claudia, et al.
Publicado: (2017)

Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
por: Sánchez-Canteli, Mario, et al.
Publicado: (2022)

Phospholipid flippases and Sfk1 are essential for the retention of ergosterol in the plasma membrane
por: Kishimoto, Takuma, et al.
Publicado: (2021)

IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma()
por: Wan, Xiaolin, et al.
Publicado: (2015)

Subcellular domain-dependent molecular hierarchy of SFK and FAK in mechanotransduction and cytokine signaling
por: Wan, Qiaoqiao, et al.
Publicado: (2017)

Roles of adenosine A(1) receptors in the regulation of SFK activity in the rat forebrain
por: Mao, Li‐Min, et al.
Publicado: (2021)

Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Grbesa, Ivana, et al.
Publicado: (2015)

Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas
por: Sánchez-Canteli, Mario, et al.
Publicado: (2021)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
por: Abou Faycal, Cherine, et al.
Publicado: (2018)

The Differential Impact of SRC Expression on the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma
por: Hermida-Prado, Francisco, et al.
Publicado: (2019)

SH2-Catalytic Domain Linker Heterogeneity Influences Allosteric Coupling across the SFK Family
por: Register, A. C., et al.
Publicado: (2014)

The diverse lives of TRAP1
por: Agorreta, Jackeline, et al.
Publicado: (2014)

Src Family Kinases (SFK) Mediate Angiotensin II-Induced Myosin Light Chain Phosphorylation and Hypertension
por: Qin, Bo, et al.
Publicado: (2015)

Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens
por: Nguewa, Paul A, et al.
Publicado: (2008)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014)

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
por: Repáraz, David, et al.
Publicado: (2022)

Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
por: Hsu, Yi-Fan, et al.
Publicado: (2010)

Phospholipid flippases and Sfk1p, a novel regulator of phospholipid asymmetry, contribute to low permeability of the plasma membrane
por: Mioka, Tetsuo, et al.
Publicado: (2018)

Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
por: Otegui, Nerea, et al.
Publicado: (2023)

DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies CREBBP as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)
por: Carazo, Fernando, et al.
Publicado: (2020)

Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer
por: Pio, Ruben, et al.
Publicado: (2010)

Dasatinib-Induced Chylothorax Beyond 5 Years of Treatment: Is There Actually Any Limit?
por: Garcia-Zamalloa, Alberto, et al.
Publicado: (2023)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022)

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge
por: Senent, Yaiza, et al.
Publicado: (2021)

Ouabain Stimulates a Na(+)/K(+)-ATPase-Mediated SFK-Activated Signalling Pathway That Regulates Tight Junction Function in the Mouse Blastocyst
por: Giannatselis, Holly, et al.
Publicado: (2011)

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
por: Bocanegra, Ana, et al.
Publicado: (2023)

TGFBI expression is associated with a better response to chemotherapy in NSCLC
por: Irigoyen, Marta, et al.
Publicado: (2010)

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations
por: Aramburu, Ander, et al.
Publicado: (2015)

SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
por: Casini, Nadia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6u0q5ju9bmvjduvspnde5hf9mf